Table 1. List of the Most Relevant Mutations in Hepatocellular Carcinoma.
De-regulated pathway | Gene | Frequency (%) | Etiology enrichment | |
---|---|---|---|---|
Telomere maintenanc | TERT | 70 | Gain of function | Alcohol |
Cell cycle control | TP53 | 30 | Loss of function | HBV |
RB1 | 8 | Loss of function | ||
CDKN2A | 8 | Loss of function | Alcohol | |
CCND1 | 7 | Gain of function | ||
CCNE1 | 5 | Gain of function | ||
Wnt signaling | CTNNB1 | 30 | Gain of function | Alcohol |
AXIN1 | 11 | Loss of function | ||
ZNRF3 | 3 | Loss of function | ||
AXIN2 | 1 | |||
APC | 1 | Loss of function | ||
Chromatin remodeling | ARID1A | 13 | Loss of function | Alcohol |
MLL4 | 10 | |||
ARID2 | 7 | |||
KMT2D | 6 | |||
KMT2B | 3 | |||
KMT2C | 2 | |||
PI3K/mTOR signaling | TSC2 | 5 | Loss of function | |
TSC1 | 3 | Loss of function | ||
DAPK1 | 3 | Loss of function | ||
PI3CA | 3 | Gain of function | ||
mTOR | 2 | Gain of function | ||
RAS/MAPK signaling | RPS6KA3 | 7 | Loss of function | |
FGF19 | 4 | Gain of function | ||
NTRK3 | 3 | |||
EPHA4 | 3 | |||
JAK/STAT signaling | IL6ST | 3 | Gain of function | |
JAK1 | 1 | |||
Oxidative stress | NFE2L2 | 6 | Gain of function | |
KEAP1 | 4 | Loss of function |